Skip to main content
Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
6.93
-0.04 (-0.57%)
At close: Nov 20, 2024, 4:00 PM
6.72
-0.21 (-3.03%)
Pre-market: Nov 21, 2024, 4:23 AM EST

Silence Therapeutics Revenue

Silence Therapeutics had revenue of 1.14M GBP in the quarter ending September 30, 2024, a decrease of -59.19%. This brings the company's revenue in the last twelve months to 16.25M, down -42.07% year-over-year. In the year 2023, Silence Therapeutics had annual revenue of 25.38M with 44.99% growth.

Revenue (ttm)
16.25M GBP
Revenue Growth
-42.07%
P/S Ratio
14.06
Revenue / Employee
149,037 GBP
Employees
109
Market Cap
324.31M USD

Revenue Chart

* This company reports financials in GBP.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202325.38M7.87M44.99%
Dec 31, 202217.50M5.09M40.97%
Dec 31, 202112.42M6.94M126.59%
Dec 31, 20205.48M5.24M2,145.49%
Dec 31, 2019244.00K--
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cerus 176.23M
Sanara MedTech 78.06M
Semler Scientific 58.94M
Alpha Teknova 36.35M
Delcath Systems 22.64M
Nyxoah 5.67M
Lexicon Pharmaceuticals 5.23M
Absci 4.21M
Revenue Rankings

SLN News

More News